You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Merck
McKinsey
Harvard Business School
Colorcon

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Details for Patent: 8,962,028

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,962,028 protect, and when does it expire?

Patent 8,962,028 protects ULTRAVATE and is included in one NDA.

This patent has twenty patent family members in seventeen countries.

Summary for Patent: 8,962,028
Title:Topical steroid composition and method
Abstract: Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include a halobetasol material comprising halobetasol or its pharmaceutically acceptable salts, esters, and solvates; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate. Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include 0.05% halobetasol propionate; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate.
Inventor(s): Johnson; Keith A. (Durham, NC), Popp; Karl F. (Schodack Landing, NY)
Assignee: MiCal Pharmaceuticals LLC--H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limited Liability Company (San Diego, CA)
Application Number:13/921,833
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,962,028
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery; Formulation; Device;

Drugs Protected by US Patent 8,962,028

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sun Pharm Industries ULTRAVATE halobetasol propionate LOTION;TOPICAL 208183-001 Nov 6, 2015 RX Yes Yes   Start Trial   Start Trial Y USE OF A LOTION CONTAINING HALOBETASOL PROPIONATE FOR THE TREATMENT OF CORTICOSTEROID-RESPONSIVE DERMATOSES INCLUDING PSORIASIS   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Medtronic
Express Scripts
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.